Crossref
Rapamycin and Cyclosporin A Alleviate Bone Marrow Adiposity in Murine Model of Aplastic Anemia
Clinical Laboratory · 2026 · 72 (03/2026)
DOI: 10.7754/clin.lab.2025.250207 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Laboratory, 2026. Verfasst von Qiuying Cao und 6 weiteren Autor:innen. Hauptthemen laut MEDLINE: Anemia, Aplastic, Cyclosporine, Sirolimus, Bone Marrow.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Anemia, AplasticCyclosporineSirolimusBone MarrowAdiposityAnimalsDisease Models, AnimalMiceImmunosuppressive AgentsMaleLipid MetabolismAdipogenesisBone Marrow Cells
Substanzen
CyclosporineSirolimusImmunosuppressive Agents
Zitieren
APA
Cao, Q., Yang, L., Liu, M., Tang, P., Liu, C., Shao, Z., & Wang, H. (2026). Rapamycin and Cyclosporin A Alleviate Bone Marrow Adiposity in Murine Model of Aplastic Anemia. Clinical Laboratory, 72(03/2026). https://doi.org/10.7754/clin.lab.2025.250207
Vancouver
Cao Q, Yang L, Liu M, Tang P, Liu C, Shao Z, et al. Rapamycin and Cyclosporin A Alleviate Bone Marrow Adiposity in Murine Model of Aplastic Anemia. Clinical Laboratory. 2026;72(03/2026). doi:10.7754/clin.lab.2025.250207
BibTeX
@article{Cao2026,
author = {Cao, Qiuying and Yang, Liping and Liu, Mengyuan and Tang, Pu and Liu, Chunyan and Shao, Zonghong and Wang, Huaquan},
title = {Rapamycin and Cyclosporin A Alleviate Bone Marrow Adiposity in Murine Model of Aplastic Anemia},
journal = {Clinical Laboratory},
year = {2026},
volume = {72},
number = {03/2026},
doi = {10.7754/clin.lab.2025.250207}
}
EUVIMED